World Health Organization Issues Guideline for Glucagon-like-Peptide-1 Therapies Use in Obesity: JAMA December 2025 Special Communication Dr. Bhumika Maikhuri19 Dec 2025 11:00 AM ISTA recent special communication highlighted that medication alone cannot solve the global obesity burden. The availability of GLP-1 therapies should...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Dr. Bhumika Maikhuri19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Lowering blood sugar cuts heart attack risk in people with prediabetes: Lancet Dr. Kamal Kant Kohli19 Dec 2025 10:00 AM ISTLowering blood sugar levels halves the likelihood of serious heart problems in people with prediabetes. According to King's College London research,...
TyG Index Strongly Predicts Subclinical Myocardial Injury, Especially in Diabetes: Study Jacinthlyn Sylvia19 Dec 2025 9:15 AM ISTA new study published in the journal of Cardiovascular Diabetology showed that for the first time, a U-shaped correlation was found between the...
Integrating Low-Cost Interventions: Yoga and Walking Demonstrate Significant Glycemic Benefit in Type 2 Diabetes Dr. Bhumika Maikhuri18 Dec 2025 12:15 PM ISTA recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type 2 diabetes, with the...
Incretin-Based Drugs Not Tied to Increased Risk of Acute Pancreatitis Among Diabetics: Study Medha Baranwal18 Dec 2025 8:45 AM ISTUSA: Researchers have found in a new study that among patients with type 2 diabetes, incretin-based medications (GLP-1 receptor agonists and DPP-4...
Diabetes Worsens Survival Outcomes in Bladder Cancer Patients: Study Dr Riya Dave17 Dec 2025 11:00 PM ISTResearchers have found in a Finnish population-based cohort study that diabetes and poor glycemic status were associated with a higher risk of overall...
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk: Study Dr. Kamal Kant Kohli17 Dec 2025 9:15 PM ISTA systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists...
Tirzepatide Linked to Lower Glaucoma Risk in Type 2 Diabetes Compared to Other Weight Loss Drugs: Study Medha Baranwal17 Dec 2025 8:45 PM ISTUSA: A large retrospective cohort study found that the dual GIP/GLP-1 receptor agonist tirzepatide was associated with a significantly reduced risk of...
Remedial action in first 2 years of diagnosis of prediabetes can Prevent Type 2 Diabetes, Indian Study Finds Jacinthlyn Sylvia17 Dec 2025 8:30 PM ISTA new study published in the Journal of Diabetes and Metabolic Disorders showed that if patients take remedial actions within the first 2 years of...
GLP-1 Receptor Agonists Linked to Reduced Liver Cancer Risk in Type 2 Diabetes: Study Medha Baranwal17 Dec 2025 9:45 AM ISTItaly: A large meta-analysis involving 2.3 million patients has found that GLP-1 receptor agonist (GLP-1 RA) use was associated with a 42% reduction...
Saturated Fat Reduction: Mortality Benefit Limited to High-Risk Individuals, Claims Study Medha Baranwal16 Dec 2025 8:45 PM ISTCanada: A meta-analysis of randomized trials has found that reducing saturated fat intake was associated with lower mortality only in individuals at...
